RecruitingPhase 2NCT06703073
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Studying Acute lung injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- PPD Development, LP
- Intervention
- Cohort A: vilobelimab(drug)
- Enrollment
- 600 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- University of Alabama Hospital, Birmingham, Alabama, United States
- Community Regional Medical Center, Fresno, California, United States
- Long Beach Memorial Medical Center, Long Beach, California, United States
- University of California Irvine Medical Center, Orange, California, United States
- University of California Davis Medical Center - Pulmonary Medicine, Sacramento, California, United States
- Denver Health Hospital and Authority, Denver, Colorado, United States
- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- Nova Clinical Research, Bradenton, Florida, United States
- North Florida / South Georgia Veterans Health System, Gainesville, Florida, United States
- Sarasota Memorial Hospital, Sarasota, Florida, United States
- St. Luke's Boise Medical Center, Boise, Idaho, United States
- Northshore University Healthsystem Research Institute, Evanston, Illinois, United States
- OSF Saint Francis Medical Center-, Peoria, Illinois, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Lahey Hospital and Medical Center, Burlington, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Biomedical Advanced Research and Development Authority · InflaRx GmbH · Edesa Biotech Inc. · Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06703073 on ClinicalTrials.govOther trials for Acute lung injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06526598Inspiratory Effort-Targeted Pressure Support Ventilation (IT-PSV) TrialCapital Medical University
- RECRUITINGNANCT07380789Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in UkraineLviv National Medical University
- RECRUITINGPHASE2, PHASE3NCT07342205A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota TransplantationShanghai University of Traditional Chinese Medicine
- RECRUITINGPHASE3NCT07208591To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress SyndromeStaidson (Beijing) Biopharmaceuticals Co., Ltd
- RECRUITINGPHASE2NCT06513949Anti-CD14 Treatment With IC14 in Hospitalized ARDS PatientsImplicit Bioscience
- RECRUITINGPHASE1, PHASE2NCT07413978A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress SyndromeChangchun Tuohua Pharmaceutical Co., Ltd.
- RECRUITINGNANCT06772025A Study to Understand How Cardiac Surgery-associated Acute Kidney Injury Develops in Participants Who Undergo Heart Surgery With the Use of Heart-lung MachineBayer
- RECRUITINGNCT07100860The Effect of Single Lung Ventilation Duration on Postoperative Pulmonary Complications in Thoracic SurgeryDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital